Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jan-Erik Frodin"'
Autor:
Sampsa Kinos, Helga Hagman, Päivi Halonen, Leena-Maija Soveri, Mary O'Reilly, Per Pfeiffer, Jan-Erik Frödin, Halfdan Sorbye, Eetu Heervä, Gabor Liposits, Raija Kallio, Annika Ålgars, Raija Ristamäki, Tapio Salminen, Maarit Bärlund, Carl-Henrik Shah, Ray McDermott, Rebecka Röckert, Petra Flygare, Johannes Kwakman, Arco Teske, Cornelis Punt, Bengt Glimelius, Pia Österlund
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: The CardioSwitch-study demonstrated that patients with solid tumors who develop cardiotoxicity on capecitabine or 5-fluorouracil (5-FU) treatment can be safely switched to S-1, an alternative fluoropyrimidine (FP). In light of
Externí odkaz:
https://doaj.org/article/340dd2f28c5441ddaf0adaf8e0022afa
Autor:
Lana Ghanipour, Gabriella Jansson Palmer, Per J. Nilsson, Caroline Nordenvall, Jan-Erik Frödin, Elinor Bexe Lindskog, Dan Asplund, Torbjörn Swartling, Wilhelm Graf, Helgi Birgisson, Ingvar Syk, Victor Verwaal, Jenny Brändstedt, Peter H. Cashin
Publikováno v:
PLoS ONE, Vol 19, Iss 3 (2024)
Externí odkaz:
https://doaj.org/article/e36fa431cccd4e7f8ea365924f4f0e3b
Autor:
Cristiana Pedone, Bruno Sorcini, Caroline Staff, Johanna Färlin, Tone Fokstuen, Jan-Erik Frödin, Per J. Nilsson, Anna Martling, Alexander Valdman
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100562- (2023)
Background and purpose: Neoadjuvant short-course radiotherapy (SCRT) followed by full-dose systemic chemotherapy is an established treatment modality in locally advanced rectal cancer (LARC). Until recently, SCRT has been exclusively delivered with p
Externí odkaz:
https://doaj.org/article/a54c8fc5ae1b4c35ba36486ef441626d
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-27 (2021)
Abstract Background Effective patient-physician communication can improve patient understanding, agreement on treatment and adherence. This may, in turn, impact on clinical outcomes and patient quality of life (QoL). One way to improve communication
Externí odkaz:
https://doaj.org/article/9f2f6767a6ab45a98a45d47a12e717c6
Autor:
Masoud Karimi, Pia Osterlund, Klara Hammarström, Israa Imam, Jan-Erik Frodin, Bengt Glimelius
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6238
Complete pathological response (pCR) is achieved in 10–20% of rectal cancers when treated with short-course radiotherapy (scRT) or long-course chemoradiotherapy (CRT) and in 28% with total neoadjuvant therapy (scRT/CRT + CTX). pCR is associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddd2be64f5423add6b09e1196398ee3d
Autor:
Francesco, Sclafani, Tae Y, Kim, David, Cunningham, Tae W, Kim, Josep, Tabernero, Hans J, Schmoll, Jae K, Roh, Sun Y, Kim, Young S, Park, Tormod K, Guren, Eliza, Hawkes, Stephen J, Clarke, David, Ferry, Jan-Erik, Frodin, Mark, Ayers, Michael, Nebozhyn, Clare, Peckitt, Andrey, Loboda, David J, Watkins
Publikováno v:
International journal of cancer. 140(2)
Limited data are available on the efficacy of anti-IGF-1R agents in KRAS mutant colorectal cancer (CRC). We analysed the outcome of 69 chemorefractory, KRAS exon 2 mutant CRC patients who were enrolled in a double-blind, randomised, phase II/III stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3cf00fb0124faa8664da9f421d6719da
https://pubmed.ncbi.nlm.nih.gov/27681944
https://pubmed.ncbi.nlm.nih.gov/27681944
Autor:
Masoud Karimi, Jenny von Salomé, Christos Aravidis, Gustav Silander, Marie Stenmark Askmalm, Isabelle Henriksson, Samuel Gebre-Medhin, Jan-Erik Frödin, Erik Björck, Kristina Lagerstedt-Robinson, Annika Lindblom, Emma Tham
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 16, Iss 1, Pp 1-11 (2018)
Abstract Background Lynch Syndrome is an autosomal dominant cancer syndrome caused by pathogenic germ-line variants in one of the DNA-mismatch-repair (MMR) genes MLH1, MSH2, MSH6 or PMS2. Carriers are predisposed to colorectal and endometrial cancer,
Externí odkaz:
https://doaj.org/article/1631392b4b01405c90c814a790407bbf